{"id":"https://openalex.org/W1980196529","doi":"https://doi.org/10.1097/00002093-200108001-00004","title":"Modulation of Nicotinic Receptor Activity in the Central Nervous System: A Novel Approach to the Treatment of Alzheimer Disease","display_name":"Modulation of Nicotinic Receptor Activity in the Central Nervous System: A Novel Approach to the Treatment of Alzheimer Disease","alternate_titles":[],"publication_year":2001,"publication_date":"2001-08-01","ids":{"openalex":"https://openalex.org/W1980196529","doi":"https://doi.org/10.1097/00002093-200108001-00004","mag":"1980196529","pmid":"https://pubmed.ncbi.nlm.nih.gov/11669505"},"language":"en","primary_location":{"id":"doi:10.1097/00002093-200108001-00004","doi":"https://doi.org/10.1097/00002093-200108001-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002093-200108001-00004","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1980196529"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109089709","display_name":"Edson Xavier Albuquerque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122140584","display_name":"Universidade Federal do Rio de Janeiro","ror":"https://ror.org/03490as77","country_code":"BR","type":"education","lineage":["https://openalex.org/I122140584"]},{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["BR","US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"E. X. Albuquerque","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201, USA. ealbuque@umaryland.edu","Departamento Farmacologia B\u00e1sica e Cl\u00ednica, Instituto de Ci\u00eancias Biom\u00e9dicas, Centro de Ci\u00eancias da Sa\u00fade Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore 21201, USA. ealbuque@umaryland.edu","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"Departamento Farmacologia B\u00e1sica e Cl\u00ednica, Instituto de Ci\u00eancias Biom\u00e9dicas, Centro de Ci\u00eancias da Sa\u00fade Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil","institution_ids":["https://openalex.org/I122140584"]},{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109087861","display_name":"M\u00e1riton D. Santos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. D. Santos","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109317552","display_name":"Manickavasagom Alkondon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. Alkondon","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088047399","display_name":"Edna F. R. Pereira","orcid":"https://orcid.org/0000-0003-0399-762X","observed_orcids":["https://orcid.org/0000-0003-0399-762X"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"E. F. R. Pereira","raw_affiliation_strings":["Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland. U.S.A","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074867425","display_name":"Alfred Maelicke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Maelicke","raw_affiliation_strings":["Laboratory of Molecular Neurobiology, Institute of Physiological Chemistry and Pathobiochemistry, Johannes-Gutenberg University Medical School, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neurobiology, Institute of Physiological Chemistry and Pathobiochemistry, Johannes-Gutenberg University Medical School, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5088047399","https://openalex.org/A5109087861","https://openalex.org/A5109089709","https://openalex.org/A5109317552"],"corresponding_institution_ids":["https://openalex.org/I122140584","https://openalex.org/I126744593"],"apc_list":null,"apc_paid":null,"fwci":1.2323,"has_fulltext":false,"cited_by_count":84,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.75838632,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"15","issue":null,"first_page":"S19","last_page":"S25"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotinic-acetylcholine-receptors","display_name":"nicotinic acetylcholine receptors","score":0.9710000157356262},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9290000200271606},{"id":"https://openalex.org/keywords/galantamine","display_name":"galantamine","score":0.8100000023841858},{"id":"https://openalex.org/keywords/allosteric-modulation","display_name":"allosteric modulation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibitors","display_name":"acetylcholinesterase inhibitors","score":0.875},{"id":"https://openalex.org/keywords/cholinergic-deficit","display_name":"cholinergic deficit","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dual-mechanism-of-action","display_name":"dual mechanism of action","score":0.6589999794960022},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.5709999799728394},{"id":"https://openalex.org/keywords/learning-and-memory","display_name":"learning and memory","score":0.5910000205039978},{"id":"https://openalex.org/keywords/receptor-expression","display_name":"receptor expression","score":0.4830000102519989}],"concepts":[{"id":"https://openalex.org/C2779056891","wikidata":"https://www.wikidata.org/wiki/Q412690","display_name":"Galantamine","level":5,"score":0.9075939655303955},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.7422403693199158},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.7134850025177002},{"id":"https://openalex.org/C22885893","wikidata":"https://www.wikidata.org/wiki/Q4862743","display_name":"Cholinergic","level":2,"score":0.6959804892539978},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.6222356557846069},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.5983651280403137},{"id":"https://openalex.org/C2776038425","wikidata":"https://www.wikidata.org/wiki/Q2649417","display_name":"Allosteric modulator","level":4,"score":0.5130156874656677},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5065680742263794},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.5051253437995911},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4889008104801178},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4256954789161682},{"id":"https://openalex.org/C2777544248","wikidata":"https://www.wikidata.org/wiki/Q2592323","display_name":"Acetylcholinesterase inhibitor","level":4,"score":0.4110298454761505},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2971256971359253},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.26266321539878845},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22724118828773499},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22237557172775269},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2117069661617279},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.15608617663383484},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.1216764748096466},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11240184307098389},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05195358395576477},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000109","descriptor_name":"Acetylcholine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000203","descriptor_name":"Activities of Daily Living","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005702","descriptor_name":"Galantamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005702","descriptor_name":"Galantamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009483","descriptor_name":"Neuropsychological Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00002093-200108001-00004","doi":"https://doi.org/10.1097/00002093-200108001-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00002093-200108001-00004","pdf_url":null,"source":{"id":"https://openalex.org/S107889856","display_name":"Alzheimer Disease & Associated Disorders","issn_l":"0893-0341","issn":["0893-0341","1546-4156"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer Disease &amp; Associated Disorders","raw_type":"journal-article"},{"id":"pmid:11669505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11669505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer disease and associated disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2888197860","display_name":"Nicotinic receptors: Role in hippocampal synaptic function","funder_award_id":"R01NS025296","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1528179691","https://openalex.org/W1939947624","https://openalex.org/W1941904320","https://openalex.org/W1955195137","https://openalex.org/W1966528911","https://openalex.org/W1972321101","https://openalex.org/W1974750975","https://openalex.org/W1979072078","https://openalex.org/W1982775869","https://openalex.org/W1991888228","https://openalex.org/W1994067502","https://openalex.org/W1996649288","https://openalex.org/W2005465170","https://openalex.org/W2005807520","https://openalex.org/W2013880114","https://openalex.org/W2014865090","https://openalex.org/W2017988828","https://openalex.org/W2018885303","https://openalex.org/W2020370964","https://openalex.org/W2021114817","https://openalex.org/W2021139758","https://openalex.org/W2022662128","https://openalex.org/W2023283315","https://openalex.org/W2025611371","https://openalex.org/W2035663078","https://openalex.org/W2038477005","https://openalex.org/W2038496535","https://openalex.org/W2039132949","https://openalex.org/W2047632293","https://openalex.org/W2057899806","https://openalex.org/W2062419094","https://openalex.org/W2068689149","https://openalex.org/W2070644314","https://openalex.org/W2076583086","https://openalex.org/W2077174214","https://openalex.org/W2089223747","https://openalex.org/W2091608383","https://openalex.org/W2093374391","https://openalex.org/W2095477109","https://openalex.org/W2102728574","https://openalex.org/W2107327698","https://openalex.org/W2110202583","https://openalex.org/W2117134611","https://openalex.org/W2133989582","https://openalex.org/W2137751464","https://openalex.org/W2149860378","https://openalex.org/W2158888678","https://openalex.org/W2243278798","https://openalex.org/W2259271415","https://openalex.org/W2262285055","https://openalex.org/W2397740639","https://openalex.org/W2417351272"],"related_works":["https://openalex.org/W2067031806","https://openalex.org/W2074526184","https://openalex.org/W29151778","https://openalex.org/W1972321101","https://openalex.org/W2091608383","https://openalex.org/W2155997108","https://openalex.org/W2043467860","https://openalex.org/W2006304751","https://openalex.org/W22442653","https://openalex.org/W2618431676"],"abstract_inverted_index":{"Impaired":[0],"cholinergic":[1,17,40,67],"function":[2,68,198],"in":[3,28,42,53,158,204,220,242],"the":[4,24,29,37,45,54,108,135,138,243],"central":[5],"nervous":[6],"system":[7],"is":[8,19,44,69,80,164],"an":[9],"early":[10],"feature":[11],"of":[12,26,36,48,78,87,92,106,114,122,137,148,180,245],"Alzheimer":[13],"disease":[14],"(AD).":[15],"Currently,":[16],"deficit":[18],"usually":[20],"corrected":[21],"by":[22,31,126,134],"increasing":[23,169],"amount":[25],"acetylcholine":[27,50],"synapse":[30],"inhibiting":[32],"acetylcholinesterase":[33],"(AChE).":[34],"One":[35,160],"most":[38],"consistent":[39],"deficits":[41],"AD":[43,246],"reduced":[46],"expression":[47],"nicotinic":[49,66,94],"receptors":[51,58],"(nAChR)":[52],"brain.":[55],"Since":[56],"these":[57,210],"are":[59,234],"essential":[60],"for":[61,199,215],"learning":[62],"and":[63,143,196,207],"memory,":[64],"restoring":[65],"a":[70,81,155,221],"promising":[71],"approach":[72],"to":[73,168,193,208,236,238],"treating":[74],"AD.":[75,159],"Allosteric":[76,96,146],"modulation":[77,113,147],"nAChR":[79,115,149,170,231],"novel":[82],"approach,":[83],"which":[84,233],"circumvents":[85],"development":[86],"tolerance":[88],"through":[89],"long-term":[90],"use":[91],"conventional":[93],"agonists.":[95],"modulators":[97],"interact":[98],"with":[99,141],"receptor-binding":[100],"sites":[101],"distinct":[102],"from":[103,184],"those":[104],"capable":[105],"recognizing":[107],"natural":[109,139],"agonist.":[110],"Positive":[111],"allosteric":[112,162],"activity":[116,150],"has":[117,190,227],"no":[118],"effect":[119],"on":[120,230],"conductance":[121],"single":[123],"channels;":[124],"instead,":[125],"facilitating":[127],"channel":[128],"opening,":[129],"it":[130],"potentiates":[131],"responses":[132],"evoked":[133],"interaction":[136],"agonist":[140],"presynaptic":[142],"postsynaptic":[144],"nAChR.":[145],"could":[151],"therefore":[152],"potentially":[153],"produce":[154],"significant":[156],"benefit":[157],"such":[161],"modulator":[163],"galantamine.":[165],"In":[166],"addition":[167],"activity,":[171],"galantamine":[172,183],"also":[173],"inhibits":[174],"AChE.":[175],"This":[176],"novel,":[177],"dual":[178],"mechanism":[179],"action":[181],"distinguishes":[182],"many":[185],"other":[186],"AChE":[187],"inhibitors.":[188],"Galantamine":[189,226],"been":[191],"shown":[192],"improve":[194],"cognitive":[195],"daily":[197],"at":[200,212,216],"least":[201,217],"6":[202],"months":[203,219],"placebo-controlled":[205],"trials,":[206],"maintain":[209],"functions":[211],"baseline":[213],"levels":[214],"12":[218],"6-month":[222],"open-label":[223],"extension":[224],"study.":[225],"positive":[228],"effects":[229],"expression,":[232],"likely":[235],"contribute":[237],"its":[239],"sustained":[240],"efficacy":[241],"treatment":[244],"patients.":[247]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1980196529","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
